Below are the most recent publications written about "Tacrolimus" by people in Profiles.
-
Holtan SG, Bola?os-Meade J, Al Malki MM, Wu J, Kitko CL, Reshef R, Rezvani AR, Shaffer BC, Solh MM, Yao JM, Runaas L, Elmariah H, Larkin KT, El Jurdi N, Gooptu M, Loren AW, Hall AC, Alousi AM, Jamy O, Clark W, Kean L, Bhatt AS, Perales MA, Applegate K, Efebera YA, Leifer E, Jones RJ, Horowitz MM, Mattila D, Saber W, Hamadani M, Martens MJ. Improved Patient-Reported Outcomes With Post-Transplant Cyclophosphamide: A Quality-of-Life Evaluation and 2-Year Outcomes of BMT CTN 1703. J Clin Oncol. 2025 03 10; 43(8):912-918.
-
Maurer K, Ho VT, Inyang E, Cutler C, Koreth J, Shapiro RM, Gooptu M, Romee R, Nikiforow S, Antin JH, Wu CJ, Ritz J, Soiffer RJ, Kim HT. Posttransplant cyclophosphamide vs tacrolimus-based GVHD prophylaxis: lower incidence of relapse and chronic GVHD. Blood Adv. 2023 08 08; 7(15):3903-3915.
-
Bola?os-Meade J, Hamadani M, Wu J, Al Malki MM, Martens MJ, Runaas L, Elmariah H, Rezvani AR, Gooptu M, Larkin KT, Shaffer BC, El Jurdi N, Loren AW, Solh M, Hall AC, Alousi AM, Jamy OH, Perales MA, Yao JM, Applegate K, Bhatt AS, Kean LS, Efebera YA, Reshef R, Clark W, DiFronzo NL, Leifer E, Horowitz MM, Jones RJ, Holtan SG. Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis. N Engl J Med. 2023 06 22; 388(25):2338-2348.
-
Bloom J, Collins ML, Belovsky MP, Feduska E, Schofield P, Leong R, Augoustides JG, Lembrikov I, Kogan A, Frogel J, Rajkumar KP, Hicks MH, Fernando RJ. Perfusion-Dependent Focal Neurologic Deficits in a Critically Ill Heart Transplant Recipient: A Case of Tacrolimus-Associated Reversible Cerebral Vasospasm Syndrome? J Cardiothorac Vasc Anesth. 2023 08; 37(8):1487-1494.
-
Belden KA, Yeager S, Schulte J, Cantarin MPM, Moss S, Royer T, Coppock D. "Saving lives with nirmatrelvir/ritonavir one transplant patient at a time". Transpl Infect Dis. 2023 Apr; 25(2):e14037.
-
Evans KB, Beermann KJ, Lee HJ, Harris M, Frankel CW, Berry H, Ali HA. Impact of Tacrolimus Trough Variability on Acute Rejection Following Lung Transplantation. Transplant Proc. 2022 Oct; 54(8):2270-2276.
-
Mansell H, Shoker A, Alcorn J, Fenton ME, Tam JS, Semchuk W, Bashir B, Kraft WK, Yao S, Douketis JD. Pharmacokinetics of apixaban and tacrolimus or cyclosporine in kidney and lung transplant recipients. Clin Transl Sci. 2022 07; 15(7):1687-1697.
-
Hissong E, Mostyka M, Yantiss RK. Histologic Features of Tacrolimus-induced Colonic Injury. Am J Surg Pathol. 2022 01 01; 46(1):118-123.
-
Bielory L, Schoenberg D. Ocular allergy: update on clinical trials. Curr Opin Allergy Clin Immunol. 2019 10; 19(5):495-502.
-
Gooptu M, Kim HT, Howard A, Choi SW, Soiffer RJ, Antin JH, Ritz J, Cutler CS. Effect of Sirolimus on Immune Reconstitution Following Myeloablative Allogeneic Stem Cell Transplantation: An Ancillary Analysis of a Randomized Controlled Trial Comparing Tacrolimus/Sirolimus and Tacrolimus/Methotrexate (Blood and Marrow Transplant Clinical Trials Network/BMT CTN 0402). Biol Blood Marrow Transplant. 2019 11; 25(11):2143-2151.